Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
- Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review but does not confirm a cure for blindness.
- Blindsight is a technology designed to help restore limited vision using microelectrode arrays embedded in the visual cortex.
- Elon Musk claimed that Blindsight could enable those who are blind to see, although experts warn that such claims are premature.
Insights by Ground AI
Does this summary seem wrong?
38 Articles
38 Articles
All
Left
1
Center
5
Right
5
Coverage Details
Total News Sources38
Leaning Left1Leaning Right5Center5Last UpdatedBias Distribution45% Center, 45% Right
Bias Distribution
- 45% of the sources are Center, 45% of the sources lean Right
45% Right
C 45%
R 45%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage